ArticleThe Journal of biological chemistry2026
Molecular mechanism of 2',3'-cGAMP degradation by monkeypox virus poxin-schlafen protein.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The cGAS-STING/MITA pathway in innate antiviral immunity and beyond.Cell insight · 2026Review
- Convergent evolution of viral nucleases targeting cyclic dinucleotides.PLoS pathogens · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The World Health Organization had declared the multiregional outbreak of monkeypox a global public health emergency twice since 2022. Poxin from orthopoxviruses degrades the second messenger 2',3'-cGAMP of the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway to evade innate immune surveillance. Monkeypox virus (MPXV) poxin is fused to schlafen and the mechanism of how it catalyzes the degradation of 2',3'-cGAMP remains unclear. Here, we show that MPXV poxin-schlafen degrades 2',3'-cGAMP into Gp[2'-5']Ap[3'], suppressing interferon-β (IFN-β) induction mediated by the cGAS-STING pathway. The schlafen domain has no impact on the degradation of 2',3'-cGAMP mediated by the poxin domain. Crystal structures of MPXV poxin domain and its complex with Gp[2'-5']Ap[3'] reveal that 2',3'-cGAMP binds to a pocket formed by two monomers of the poxin dimer and induces closure of the pocket to trigger degradation. MPXV poxin exhibits a strict substrate specificity and does not degrade 3',3'-cGAMP, c-di-AMP, and c-di-GMP that also activate STING-mediated immune responses. These results unveil the molecular mechanism for 2',3'-cGAMP degradation by MPXV poxin-schlafen protein and provide the structural basis for the development of inhibitors against MPXV infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.